Floatz logo

Mesna

Hodgkin's Lymphoma

St. Jude Children's Research HospitalSmall moleculePhase 2Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Hodgkin's Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
St. Petersburg State Pavlov Medical University
Phase 3BBB
PEGFILGRASTIM
Michael Spinner, MD
Phase 3BB
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Weill Medical College of Cornell University
Phase 2BB
Ruxolitinib
Seda S. Tolu
Phase 2BB
Panobinostat
OHSU Knight Cancer Institute
Phase 3BB

View all 46 →

Same molecule, other indications

Mesna is also rated in:

disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
69 / 100
View asset →
NK/T-cell LymphomaDormant
BB
Indicative ·
67 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →